Merck progresses toward completion of Sigma-Aldrich acquisition
Closing of transaction expected within next two months
Sigma-Aldrich shareholders approved the merger with Merck. Merck has also completed its capital markets activities to finance the transaction with the placement of a € 2.1 billion bond.
The planned acquisition of Sigma-Aldrich for approximately US$ 17 billion (€ 13.1 billion), which was announced in September 2014, is a key element of Merck’s “Fit for 2018” transformation and growth program. Establishing one of the leading players in the $ 130 billion global life science industry, the transaction presents an opportunity for both companies and their customers. Once the transaction has been completed, Merck will be able to serve life science customers around the world with a highly attractive set of established brands and an efficient supply chain that can support the delivery of more than 300,000 products.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.